Insider · CIK 0001341642

Mack David Henry

Reports to the SEC for 4 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001341642

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-05	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+745K sh	—	—	744,960
2025-10-27	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+221K sh	$1.37	+$302K	451,109
2025-10-27	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−221K sh	—	—	0
2025-07-01	PMVPPMV Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−58.4K sh	$1.06	−$62.2K	536,133
2025-03-03	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+800K sh	—	—	800,000
2025-01-03	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+17.7K sh	$0.53	+$9,385.77	551,919
2025-01-03	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−17.7K sh	—	—	0
2024-12-03	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+91.8K sh	$0.53	+$48.6K	534,210
2024-12-03	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−91.8K sh	—	—	17,709
2024-08-13	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−135K sh	—	—	0
2024-08-13	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−250K sh	—	—	0
2024-08-13	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+384K sh	—	—	384,184
2024-08-13	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−330K sh	—	—	0
2024-08-13	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+330K sh	—	—	330,000
2024-01-18	PMVPPMV Pharmaceuticals, Inc.A Award	Director, President and CEO	AAward	+164K sh	—	—	442,460
2024-01-18	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+520K sh	—	—	519,915
2023-11-10	PMVPPMV Pharmaceuticals, Inc.G Gift	Director, President and CEO	GGift	−85.3K sh	—	—	278,570
2023-11-10	PMVPPMV Pharmaceuticals, Inc.G Gift	Director, President and CEO	GGift	+85.3K sh	—	—	165,307
2023-10-18	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+198K sh	$0.53	+$105K	363,877
2023-08-07	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−198K sh	—	—	109,459
2023-08-07	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+85.5K sh	$0.53	+$45.3K	165,470
2023-08-07	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−85.5K sh	—	—	307,866
2023-05-12	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+330K sh	—	—	330,000
2022-04-27	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+33K sh	$0.53	+$17.5K	79,970
2022-04-27	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−33K sh	—	—	393,366
2022-03-08	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+20K sh	$1.37	+$27.4K	46,970
2022-03-08	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−20K sh	—	—	220,644
2022-02-10	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, President and CEO	AAward	+250K sh	—	—	249,600
2021-12-15	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+9,000 sh	$0.53	+$4,770	26,970
2021-12-15	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−9,000 sh	—	—	432,574
2021-12-09	PMVPPMV Pharmaceuticals, Inc.G Gift	Director, President and CEO	GGift	−40K sh	—	—	187,915
2021-12-09	PMVPPMV Pharmaceuticals, Inc.G Gift	Director, President and CEO	GGift	+40K sh	—	—	40,000
2021-08-19	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+5,500 sh	$0.53	+$2,915	17,970
2021-08-19	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−5,500 sh	—	—	441,574
2021-07-21	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+26.8K sh	$0.53	+$14.2K	39,237
2021-07-21	PMVPPMV Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−26.8K sh	$35.76	−$957K	12,470
2021-07-21	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−26.8K sh	—	—	447,074
2021-07-20	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,029 sh	$0.53	+$545.37	13,499
2021-07-20	PMVPPMV Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−1,029 sh	$35.53	−$36.6K	12,470
2021-07-20	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−1,029 sh	—	—	473,841
2021-06-28	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+204 sh	$0.53	+$108.12	12,674
2021-06-28	PMVPPMV Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−204 sh	$35.53	−$7,248.12	12,470
2021-06-28	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−204 sh	—	—	474,870
2021-05-21	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+6,207 sh	$0.53	+$3,289.71	8,677
2021-05-21	PMVPPMV Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−6,207 sh	$35.71	−$222K	2,470
2021-05-21	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−6,207 sh	—	—	485,074
2021-05-21	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10K sh	—	—	475,074
2021-05-20	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,793 sh	$0.53	+$4,130.29	10,263
2021-05-20	PMVPPMV Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−7,793 sh	$35.60	−$277K	2,470
2021-05-20	PMVPPMV Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,793 sh	—	—	492,867

Recent filings

Accepted (ET)
Mar 94
Mack David Henry0001341642-26-000002
SEC(opens sec.gov)
Oct 294
Mack David Henry0001341642-25-000004
SEC(opens sec.gov)
Jul 34
Mack David Henry0001415889-25-019380
SEC(opens sec.gov)
Mar 54
Mack David Henry0001415889-25-007071
SEC(opens sec.gov)
Jan 224
Mack David Henry0001415889-25-001853
SEC(opens sec.gov)
Oct 34
Mack David Henry0001415889-24-024622
SEC(opens sec.gov)
Jan 224
Mack David Henry0001209191-24-001993
SEC(opens sec.gov)
Nov 134
Mack David Henry0001209191-23-054997
SEC(opens sec.gov)

Companies

Address

C/O PMV PHARMACEUTICALS, INC. 400 ALEXANDER PARK DRIVE, SUITE 301

PRINCETON, NJ, 08540